RecruitingNCT06521047

A Multicentre Observational Study to Assess Long-term Outcome of Participants in the EXCELLENT Clinical Trial


Sponsor

CellProthera

Enrollment

48 participants

Start Date

Jul 20, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The PERFECT study is an observational study designed to follow patients randomised in the EXCELLENT study (NCT02669810) for 10 years. The aim is to assess the long-term clinical outcomes for patients randomised to the Standard of Care arm or the ProtheraCytes arm.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying NA - Observational study for people with acute myocardial infarction. The study is currently recruiting participants at 10 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNA - Observational study

Observational study, data collection only.


Locations(10)

GHRMSA

Mulhouse, France, France

CHU DIJON Hôpital François Mitterrand 14 rue Gaffarel

Dijon, France

Institut Jacques Cartier

Massy, France

CHU Montpellier Arnaud-De-Villeneuve

Montpellier, France

Hôpital Haut Levèque

Pessac, France

Hôpital de Rangueil

Toulouse, France

Ninewells Hospital & Medical School

Dundee, United Kingdom

BIRMINGHAM, Queen Elizabeth Hospital ,Mindelsohn Way,

Edgbaston, United Kingdom

University of Edinburgh

Edinburgh, United Kingdom

Saint Bartholomew's Hospital W Smithfield,

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06521047


Related Trials